Search - tctmd.com

Displaying 1 - 20 of 281

Sort: Relevancy | Date

News Conference News TCT 2025

‘Investing’ in CTOs With Staged PCI Seems to Pay Off in Safety Gains

Yael L. Maxwell

November 05, 2025

News Conference News TCT 2025

What Makes MedTech Great—or Not—and Envisioning Its Future

Caitlin E. Cox

November 04, 2025

News Conference News TCT 2025

AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations

Todd Neale

October 31, 2025

News Conference News TCT 2025

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Yael L. Maxwell

October 28, 2025

News Conference News TCT 2025

PROCTOR: PCI of Failed Bypass Grafts Tops Native-Vessel PCI, With Caveats

Todd Neale

October 28, 2025

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

Presentation TCT 2025

TCT 498: Comparative Effectiveness of GLP-1 Receptor Agonists vs. SGLT2 Inhibitors on Cardiovascular Outcomes in Patients with Diabetes Undergoing Percutaneous Coronary Intervention

Presenter: Ahmed A. Mahmoud

October 28, 2025

Presentation TCT 2025

TCT 494: Cost-Effectiveness of SGLT2 Inhibitors, Statins, and GLP-1 Receptor Agonists for Cardiovascular Secondary Prevention: A Comparative Analysis

Presenter: Mehmet Cilingiroglu

October 28, 2025

Presentation TCT 2025

TCT 499: Impact of GLP-1 Agonists on Cardiovascular Outcomes in Obese Adults with HFrEF receiving Guideline Directed Medical Therapy: A Propensity Score Matched Analysis

Presenter: Dawood Shehzad

October 28, 2025

Presentation TCT 2025

TCT 491: Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled studies

Presenter: Claudio Laudani

October 28, 2025

Presentation TCT 2025

TCT 492: Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular Outcomes Post-PCI in Patients with Diabetes: Findings from the TriNetX Database

Presenter: Aymen Ahmed

October 28, 2025

Presentation TCT 2025

TCT 488: Sex-Based Differences in Cardiovascular Outcomes With Achieved LDL-C <55 mg/dL: A Comparative Cohort Analysis

Presenter: Mehmet Cilingiroglu

October 28, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

TCT 964: Invisible Enemies of the Heart: An Umbrella Review of PM2.5 Exposure and Cardiovascular Risk Across Global Populations

Presenter: Yashendra Sethi

October 27, 2025

Presentation TCT 2025

TCT 1206: Clinical Presentation and Long-Term Outcomes of Patients Without Standard Modifiable Cardiovascular Risk Factors: Insight from the DECADE Cooperation

Presenter: Claudio Laudani

October 27, 2025

Presentation TCT 2025

First Report of the SPYRAL AFFIRM Study: Reduced Home and Office Blood Pressure Following Radiofrequency Renal Denervation in a Large US Cohort of High Cardiovascular Risk Patients.

Presenter: Felix Mahfoud

October 27, 2025

Presentation TCT 2025

TCT 1283: Clinical Presentation and Long-Term Outcomes of Patients Without Standard Modifiable Cardiovascular Risk Ffactors: Insight from the DECADE Cooperation

Presenter: Claudio Laudani

October 27, 2025

Presentation TCT 2025

TCT 485: Lipoprotein(a) and Long-Term Cardiovascular Events in Patients With Coronary Vasospasm

Presenter: Melly Susanti

October 27, 2025

Presentation TCT 2025

TCT 476: Synergistic Impact of Insulin Resistance and Hepatic Fibrosis on Cardiovascular Events in Patients with Coronary Artery Disease: A Machine Learning Subtyping and Interaction Analysis

Presenter: Zhihao Zheng

October 27, 2025

Presentation TCT 2025

TCT 894: Development and Internal Validation of an AI-Driven Model for 5-Year Cardiovascular Disease Risk Prediction in the Canadian Longitudinal Study on Aging : Comparative Performance vs. Traditional Risk Scores

Presenter: Robert Avram

October 27, 2025

Advertisement

‘Investing’ in CTOs With Staged PCI Seems to Pay Off in Safety Gains

What Makes MedTech Great—or Not—and Envisioning Its Future

AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

PROCTOR: PCI of Failed Bypass Grafts Tops Native-Vessel PCI, With Caveats

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

TCT 498: Comparative Effectiveness of GLP-1 Receptor Agonists vs. SGLT2 Inhibitors on Cardiovascular Outcomes in Patients with Diabetes Undergoing Percutaneous Coronary Intervention

TCT 494: Cost-Effectiveness of SGLT2 Inhibitors, Statins, and GLP-1 Receptor Agonists for Cardiovascular Secondary Prevention: A Comparative Analysis

TCT 499: Impact of GLP-1 Agonists on Cardiovascular Outcomes in Obese Adults with HFrEF receiving Guideline Directed Medical Therapy: A Propensity Score Matched Analysis

TCT 491: Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled studies

TCT 492: Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular Outcomes Post-PCI in Patients with Diabetes: Findings from the TriNetX Database

TCT 488: Sex-Based Differences in Cardiovascular Outcomes With Achieved LDL-C <55 mg/dL: A Comparative Cohort Analysis

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

TCT 964: Invisible Enemies of the Heart: An Umbrella Review of PM2.5 Exposure and Cardiovascular Risk Across Global Populations

TCT 1206: Clinical Presentation and Long-Term Outcomes of Patients Without Standard Modifiable Cardiovascular Risk Factors: Insight from the DECADE Cooperation

First Report of the SPYRAL AFFIRM Study: Reduced Home and Office Blood Pressure Following Radiofrequency Renal Denervation in a Large US Cohort of High Cardiovascular Risk Patients.

TCT 1283: Clinical Presentation and Long-Term Outcomes of Patients Without Standard Modifiable Cardiovascular Risk Ffactors: Insight from the DECADE Cooperation

TCT 485: Lipoprotein(a) and Long-Term Cardiovascular Events in Patients With Coronary Vasospasm

TCT 476: Synergistic Impact of Insulin Resistance and Hepatic Fibrosis on Cardiovascular Events in Patients with Coronary Artery Disease: A Machine Learning Subtyping and Interaction Analysis

TCT 894: Development and Internal Validation of an AI-Driven Model for 5-Year Cardiovascular Disease Risk Prediction in the Canadian Longitudinal Study on Aging : Comparative Performance vs. Traditional Risk Scores

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content